Sign In
Buy AXSM
$233.49
+11.33 (+5.10%)
At Close: Jun 03, 2026
Why Axsome Therapeutics Stock Caught Fire in September
10:45am, Wednesday, 06'th Oct 2021
This beaten-down biotech regained some lost ground last month.
NEW YORK, Sept. 29, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Axsome Therapeutics,
2 Best Biotech Stocks to Buy Right Now
07:00am, Saturday, 25'th Sep 2021
Aurinia Pharmaceuticals and Axsome Therapeutics are two names that growth investors should have on their radars right now.
Do Options Traders Know Something About Axsome (AXSM) Stock We Don't?
03:21pm, Friday, 24'th Sep 2021
Investors need to pay close attention to Axsome (AXSM) stock based on the movements in the options market lately.
Axsome Therapeutics: Amid The FDA Difficulty Is A Huge Opportunity
04:28am, Friday, 24'th Sep 2021
Among various companies being negatively impacted by a hypersensitive FDA environment, Axsome Therapeutics shares recently tumbled. Amid the aforesaid debacle, AXS-05 received a "stand by" notice from
Why Wall Street Thinks This Biotech Stock Can Triple Your Money
06:43am, Thursday, 23'rd Sep 2021
The risks are huge, but so are the potential returns.
Axsome Therapeutics Stock Rises 36% In A Month But Will The Rally Continue?
06:30am, Monday, 20'th Sep 2021
A couple of months back we discussed that Axsome Therapeutics stock is likely to rebound after it fell nearly 20% in a month following the U.S. FDA's decision to pull the breakthrough therapy designat
Axsome (AXSM) Begins Late-Stage Sleep Disorder Study on AXS-12
11:28am, Friday, 17'th Sep 2021
Axsome (AXSM) is developing AXS-12 as a potential treatment for narcolepsy. The company initiates enrollment in a phase III study evaluating AXS-12.
Axsome Therapeutics Initiates SYMPHONY Phase 3 Trial of AXS-12 in Narcolepsy
07:00am, Thursday, 16'th Sep 2021
NEW YORK, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorde
AXSM Stock: Why It Increased Today
08:48am, Tuesday, 14'th Sep 2021
The stock price of Axsome Therapeutics Inc (NASDAQ: AXSM) increased over 5% pre-market today. This is why it happened.
Axsome Therapeutics Inc Ranked Among Today's Top Shorts After The European Central Bank Says It May Slow Down Bond Purchases
10:43am, Thursday, 09'th Sep 2021
The Dow Jones dipped about 40 points, the S&P 500 was flat, and the Nasdaq saw some mild gains, led by Big Tech stocks such as Apple, Facebook, and Amazon. Find opportunities in today's market with th
Why Axsome Therapeutics Stock Cratered in August
02:15pm, Wednesday, 08'th Sep 2021
An unexpected regulatory setback weighed heavily on the biotech's shares last month.
Axsome (AXSM) Up 11.7% Since Last Earnings Report: Can It Continue?
01:16pm, Wednesday, 08'th Sep 2021
Axsome (AXSM) reported earnings 30 days ago. What's next for the stock?
3 Biotech Stocks Wall Street Expects to Double Soon
07:03am, Tuesday, 07'th Sep 2021
All three stocks on this list can more than double your money according to investment bank analysts who cover them.
Buy, Sell, or Hold Axsome Therapeutics Stock After Its FDA Approval Delay?
09:55am, Sunday, 05'th Sep 2021
There are still plenty of unknowns related to Axsome's FDA filing.
